Basic Information
| LncRNA/CircRNA Name | PRCAT38 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | qPCR etc. |
| Sample | prostate cancer tissues, cell line (PC4) |
| Expression Pattern | up-regulated |
| Function Description | Our data revealed that the expression levels of PRCAT17.3 (P<0.0001) and PRCAT38 (P<0.0002) were significantly upregulated in human prostate cancer tissues, compared to BPH ones. Moreover, the altered expression was much higher for PRCAT17.3 (??000 folds) than PRCAT38 (??0 folds). |
| Pubmed ID | 29671889 |
| Year | 2018 |
| Title | Two long non-coding RNAs, Prcat17.3 and Prcat39, could efficiently discriminate benign prostate hyperplasia from prostate cancer. |
External Links
| Links for PRCAT38 | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |